Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-27 @ 12:10 PM
Study NCT ID:
NCT00792467
Status:
COMPLETED
Last Update Posted:
2021-05-11
First Post:
2008-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma
Sponsor:
Italfarmaco
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DSC/07/2357/31
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None